HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

502.512

+19.3574.01%

Number of Gainers:24

Number of Losers:6

Number of Flat:3

PE:- -

High:504.211

Open:483.278

Low:478.821

Close:483.155

Volume:109.56M

Turnover:3.00B

Market Cap:318.64B

Float Cap:283.64B

Loading ...

Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones

Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum

Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7

Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each

SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit

Ascletis Pharma Joins Two Chinese Stock Connect Programs

MT Newswires Live

HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects

MT Newswires Live

CStone Pharmaceuticals Joins Stock Connect Southbound Trading

MT Newswires Live

Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results

MT Newswires Live

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK1574/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":502.51205,"timestamp":1789373282104,"preClose":483.15506,"halted":0,"volume":109559454,"delay":0,"changeRate":0.040064,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":19.356995,"latestTime":"09-14 16:00:00","open":483.2777,"high":504.2106,"low":478.82104,"amount":2997572701.5,"amplitude":0.05255,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":3.744174,"peRate":166.585651,"turnoverRate":0.004111,"increases":23,"decrements":7,"flats":2,"marketCap":318641943840,"floatMarketCap":283642599432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":504.2106,"amplitude":0.05255,"preClose":483.15506,"low":478.82104,"pbRate":"3.744174","latestPrice":502.51205,"volume":109559454,"delay":0,"open":483.2777,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":516.325,"twentyDayClose":505.128,"sixtyDayClose":444.911,"secType":"PLATE","market":"HK","turnoverRate":0.004111,"peRate":166.585651,"marketCap":318641943840,"floatMarketCap":283642599432,"timestamp":1789373282104,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":24,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188251172","title":"Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1188251172","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188251172?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:44","pubTimestamp":1788846259,"startTime":"0","endTime":"0","summary":"Portfolio Alert: HK-Listed CSTONE PHARMA-B Surges 6% on Stock Connect Inclusion and Global Trial MilestonesCSTONE PHARMA-B (02616) witnessed a strong afternoon rally on Tuesday, climbing more than 6%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","FLHK","161027","BK1161","BK4585","BK4588","BK1574","VXUS","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167357330","title":"Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1167357330","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167357330?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:56","pubTimestamp":1788839775,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) saw its share price climb more than 5% during morning trading on Wednesday. As of the time of writing, the stock was up 4.73% to HK$32.78, with trading turnover reaching HK$151...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1583","BK1574","01952","KCAI","VXUS","BK4588","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106413707","title":"China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1106413707","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106413707?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:34","pubTimestamp":1788838468,"startTime":"0","endTime":"0","summary":"China Securities has released a research note indicating that the medical device sector maintained its revenue growth trajectory in Q2, with quarterly profit growth turning positive for the first...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","HART","09996","IEIH","601066","BK1574","GDOC","BK1583","LNGR","MEDX","PTH","BK0276","MDEV","BK1100","RSPH","159883","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183000307","title":"Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1183000307","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183000307?lang=en_us&edition=fundamental","pubTime":"2026-09-08 10:22","pubTimestamp":1788834140,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) shares climbed more than 6% in Monday's session, trading up 6.02% at HK$28.52 as of the time of writing. The stock recorded a turnover of HK$6.452 million with a volume ratio of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","HSCI","KCAI","BK1191","VXUS","BK1161","BK1515","BK4585","FLHK","159938","09939","09637","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169256250","title":"Major Shift in Sell-Side Research: Healthcare Analyst Switches to Semiconductors","url":"https://stock-news.laohu8.com/highlight/detail?id=1169256250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169256250?lang=en_us&edition=fundamental","pubTime":"2026-09-07 22:10","pubTimestamp":1788790245,"startTime":"0","endTime":"0","summary":"Sell-side research has witnessed a notable career pivot as a healthcare-focused analyst has transitioned to covering the electronics sector, marking a significant departure from their academic and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","KCE","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311564","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311564","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311564?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:12","pubTimestamp":1788783177,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buyback cancellationZylox-Tonbridge repurchased 53,500 H shares on Sept. 7, 2026 for holding as treasury shares; no shares were cancelled","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL100F5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1574","02190","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1574","IBBQ","BK1161","MEDX","159992","KSTR","06978","BK0262","688488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135498525","title":"Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1135498525","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135498525?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:21","pubTimestamp":1788780087,"startTime":"0","endTime":"0","summary":"More than two years have passed since the failed acquisition, and the 60% equity stake in Jinan Pingjia is once again on the property rights trading market, now with a minimum listing price of 24...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0209","09939","BK1574","BK1515","301017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","BK1583","IBBQ","LU2488822045.USD","BK1161","LNGR","MEDX","KSTR","LU2328871848.SGD","159992","09995","LU1064130708.USD","LU1064131003.USD","BK0239","BK1574","06978","LU2148510915.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179966506","title":"ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1179966506","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179966506?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:20","pubTimestamp":1788776414,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that on September 7, 2026, it spent HK$989,200 to repurchase 115,000 shares.The buyback reflects the company's ongoing capital management strategy, with the repurchased...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315451","title":"Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315451","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315451?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:16","pubTimestamp":1788776202,"startTime":"0","endTime":"0","summary":"Alphamab Oncology files HKEX next-day return disclosing share repurchase at HKD 8.6 eachAlphamab Oncology repurchased 115,000 ordinary shares on Sept. 7, holding all as treasury shares.Buyback price r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL4b0tJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665200318","title":"SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2665200318","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665200318?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:07","pubTimestamp":1788772023,"startTime":"0","endTime":"0","summary":"SinoMab BioScience held shareholder meeting, disposal resolution drew 100% supportSinoMab BioScience held an extraordinary general meeting on Sept. 7, 2026.Shareholders adopted a resolution to confirm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL9Tlkd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182662414","title":"Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future","url":"https://stock-news.laohu8.com/highlight/detail?id=1182662414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182662414?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:21","pubTimestamp":1788769307,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Anglikang Pharmaceutical Co.,Ltd. (002940.SZ) briefly hit the daily limit up on September 4th, buoyed by news of medical insurance negotiations and the launch of commercial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK0239","06978","002940","MEDX","159992","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142074973","title":"Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1142074973","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142074973?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:28","pubTimestamp":1788766134,"startTime":"0","endTime":"0","summary":"Suzhou Zelgen Biopharmaceuticals Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange main board, marking its second attempt, with China International Capital Corporation...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEXmain","688266","01477","BK1574","BK1191","BK0239","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665474394","title":"Ascletis Pharma Joins Two Chinese Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665474394","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665474394?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:34","pubTimestamp":1788762852,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective Sept. 7.The inclusion allows mainland Chinese investors to trade the biotech company's Hong Kong-listed shares through the Stock Connect platform, according to a Monday Hong Kong bourse filing.Shares of the drugmaker rose over 2% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CHAU","02822","82823","82822","01672","YINN","BK1574","02823","KBA","FXP","YANG","YXI","02843","82843","BK1515","BK1161","KWEB","ASHR","KCAI","ASHS","FLCH","CWEB","XPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665941093","title":"HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects","url":"https://stock-news.laohu8.com/highlight/detail?id=2665941093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665941093?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:29","pubTimestamp":1788762578,"startTime":"0","endTime":"0","summary":"HBM Holdings'  shares have been included as eligible stocks under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, according to a Monday bourse filing with the Hong Kong bourse.Qualified investors in mainland China can now directly invest in the company's shares through these Stock Connect programs.Shares of the biopharmaceutical company fell 1% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CWEB","02142","ASHS","YXI","02823","HBMX","82843","DRMY","MUG","FLCH","YINN","MUYY","BK1583","BK1161","RAM","KWEB","DRMP","02843","BK1574","CHAU","ASHR","BK4588","MULL","KCAI","82822","DRAM","MUZ","MUU","02822","DRAL","XPP","YANG","FXP","KBA","MIC","82823","DISK","RAMZ","MUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665943143","title":"CStone Pharmaceuticals Joins Stock Connect Southbound Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2665943143","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665943143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761498,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (HKG:2616) said its Hong Kong-listed shares have been added to the eligible securities list for southbound trading under Stock Connect, effective Sept. 7, according to a same-day Hong Kong bourse filing.Shares of the biopharmaceutical company fell nearly 1% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02823","BK1161","KCAI","KBA","82843","KWEB","BK1574","CHAU","FXP","82822","02843","XPP","YANG","YINN","ASHR","02822","82823","ASHS","02616","YXI","CWEB","FLCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992903","title":"Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992903","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992903?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:11","pubTimestamp":1788757872,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical  has disclosed positive results from the long-term safety trial of its skin tone correcting treatment, KT-939, according to a Monday bourse filing.Preliminary data showed that KT-939 was safe and well-tolerated, and participants treated with it for about a year did not experience any adverse skin reactions, the company said.Kintor said it is now working to advance KT-939's registration application for approval by the National Medical Products Administration before launching it commercially.The company's shares are up 5.5% in midday trading on the HKEX.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155170383","title":"Medical Device Inspection Campaign Launched by Ningyang County Market Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1155170383","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155170383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:41","pubTimestamp":1788756073,"startTime":"0","endTime":"0","summary":"On September 7, enforcement officers from the Market Supervision Administration of Ningyang County, Shandong Province, visited retail pharmacies within their jurisdiction to conduct a targeted...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","159883","GDOC","BK1574","BK1100","MDEV","LNGR","RSPH","LGHT","HART","PTH","MEDX","IEIH","09996","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894169","title":"MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894169?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754720,"startTime":"0","endTime":"0","summary":"As a wave of interim earnings reports floods in from medical device companies, the sector's recovery trajectory has become increasingly clear, with a definitive upward inflection point now visible in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","09996","BK1583","159883","VXUS","BK1574","BK4588","RSPH","LNGR","LGHT","BK1100","AGNG","GDOC","HART","02041","BK4585","KCAI","MDEV","MEDX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":7,"totalSize":238,"code":"91000000","status":"200"}]}}